ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 180 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,633 | -22.7% | 158 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $7,289 | +15.0% | 158 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $6,336 | +92.6% | 158 | +122.5% | 0.00% | +50.0% |
| Q4 2022 | $3,289 | +9.6% | 71 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | -25.0% | 71 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,000 | +33.3% | 71 | +91.9% | 0.00% | 0.0% |
| Q4 2021 | $3,000 | 0.0% | 37 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $3,000 | -25.0% | 37 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 37 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | -33.3% | 37 | -22.9% | 0.00% | -50.0% |
| Q4 2020 | $6,000 | +50.0% | 48 | -43.5% | 0.00% | +33.3% |
| Q3 2019 | $4,000 | -33.3% | 85 | -9.6% | 0.00% | -25.0% |
| Q2 2019 | $6,000 | -14.3% | 94 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $7,000 | 0.0% | 94 | -3.1% | 0.01% | +66.7% |
| Q3 2018 | $7,000 | – | 97 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
| CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
| Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
| Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
| Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
| Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
| Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
| Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
| ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |